Tata Trust and The Global Fund backed Indian Health Fund (IHF) has chosen four innovators for early detection of Tuberculosis (TB) and Malaria to effectively tackle & eradicate these diseases.
a. Indian Health Fund (IHF)
b. National Health Fund (NHF)
c. All India Health Fund (AIHF)
d. None of the above
- Three selected innovators are related to TB and one to Malaria.
- They were selected from proposals received for its second Request for Proposals.
Details:
- The aim for selecting these innovators is at leveraging technology for improving early detection and prompt treatment along with promoting diagnostics feasible for primary health care facilities.
- It also aims to supporting national efforts to effectively tackle & eradicate these diseases which are crucial health challenges in India.
- Government has set a target of eliminating TB by 2025 and Malaria by 2030.
- India contributes to 27% of the global TB burden and 68% of all Malaria cases in the Southeast Asia region.
About Indian Health Fund (IHF):
- IHF was launched in 2016 by Tata Trusts in collaboration with The Global Fund, to drive innovations towards key infectious disease challenges in India.
- It supports individuals and organisations with already germinated innovative strategies, services, products, such that they become sustainable and scalable solutions in addressing TB and Malaria.
- The initiative is not a fellowship programme to do research from scratch.
- It is a long-term exercise aligned with the country's goal of eliminating TB by 2025 and Malaria by 2030.
- It will promote innovative solutions such that they are widely accessible and are affordable.
Question:
Q. Which fund backed by Tata Trust and The Global Fund has chosen four innovators for early detection of Tuberculosis (TB) and Malaria to effectively tackle & eradicate these diseases?a. Indian Health Fund (IHF)
b. National Health Fund (NHF)
c. All India Health Fund (AIHF)
d. None of the above
